Downregulation of miR-154 in cervical cancer and its clinicopathological and prognostic significance

Chunru Wu,Hailiang Xu,Meiyue Zhang,Chunlin Liu,Aiqing Zhou,Quanqin He,Jinfeng Li,Yunyun Feng,Yonggang Zhang
Abstract:Objective: miR-154 has been reported to be downregulated in many human malignancies and function as a tumor suppressor. However, its role in cervical cancer is still unclear. The aim of this study was to investigate the clinical significance and prognostic value of miR-154 expression in cervical cancer. Methods: The expression of miR-154 was detected in 135 pairs of cervical cancer specimens and adjacent noncancerous tissues using qRTPCR assay. Then, the association of miR-154 levels with clinicopathological features and prognosis was evaluated. Results: MiR-154 expression was significantly downregulated in cervical cancer tissues than those corresponding noncancerous tissues (P < 0.001). Decreased miR-154 expression was linked to lymph node metastasis, vascular invasion, poor tumor differentiation, advanced FIGO stage, and short overall survival. Multivariate Cox regression analysis confirmed that low level of miR-154 expression predicted poor prognosis of patients with cervical cancer independently .Conclusions: Our results suggest that miR-154 downregulation may be involved in cervical cancer formation and progression, and that miR-154 would serve as a novel prognostic biomarker for patients with this disease.
What problem does this paper attempt to address?